Open AccessEfficacy of Azithromycin for Treatment of Acute Exacerbation of Chronic Fibrosing Interstitial Pneumonia: A Prospective, Open-Label Study with Historical Controls
Author(s) -
Kodai Kawamura,
Kazuya Ichikado,
Moritaka Suga,
Masakazu Yoshioka
Publication year - 2014
Publication title -
respiration
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.264
H-Index - 81
eISSN - 1423-0356
pISSN - 0025-7931
DOI - 10.1159/000358443
Subject(s) - medicine , azithromycin , exacerbation , gastroenterology , adverse effect , prospective cohort study , pneumonia , hazard ratio , surgery , antibiotics , confidence interval , microbiology and biotechnology , biology
Acute exacerbation of chronic fibrosing interstitial pneumonia (AE-CFIP) is an often fatal condition with no established treatment. Recently, macrolides were found to be beneficial in cases of acute lung injury.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom